Core Laboratories
CLB
320 hedge funds and large institutions have $2.88B invested in Core Laboratories in 2018 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 128 reducing their positions, and 83 closing their positions.
4.69% less ownership
Funds ownership: 113.36% → 108.67% (-4.7%)
11% less funds holding
Funds holding: 359 → 320 (-39)
27% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 128
41% less call options, than puts
Call options by funds: $5M | Put options by funds: $8.55M
45% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 83
50% less capital invested
Capital invested by funds: $5.78B → $2.88B (-$2.9B)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$61.4M |
| 2 |
Millennium Management
New York
|
+$50.6M |
| 3 |
Select Equity Group
New York
|
+$46M |
| 4 |
Renaissance Technologies
New York
|
+$23.7M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$23.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
-$130M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$60.5M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$48.1M |
| 4 |
WP
Wedgewood Partners
St Louis,
Missouri
|
-$36.1M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$25.3M |
CLB Hedge Fund Activity: Q4 2018 in Review
320 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2018, worth a combined $2.88B — down 50% from $5.78B a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of CLB and 46 opened new positions — a net loss of 37 holders — while 128 trimmed existing stakes and 93 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $61.4M. The largest seller was Royal London Asset Management, cutting an estimated $130M.
- 320 institutional investors held Core Laboratories (CLB) as of Q4 2018, down from 359 in Q3 2018.
- Funds reported $2.88B of Core Laboratories stock for Q4 2018, down 50% quarter-over-quarter.
- 46 funds opened new Core Laboratories positions in Q4 2018 and 83 closed out, a net change of -37 holders.
- The largest Core Laboratories buyer in Q4 2018 was Massachusetts Financial Services, an estimated $61.4M added.
- The largest Core Laboratories seller in Q4 2018 was Royal London Asset Management, an estimated $130M sold.
Based on aggregated 13F filings for Q4 2018.